3 days popular7 days popular1 month popular3 months popular

Pancreatic Cancer Patients Benefit From Erlotinib Added To Bevacizumab/Chemoradiotherapy Regimen

The addition of high doses of erlotinib to the treatment regimen of bevacizumab and capecitabine with radiotherapy seems to benefit patients with locally advanced pancreatic cancer, according to results of a phase I study presented at the American Association for Cancer Research’s Pancreatic Cancer: Progress and Challenges conference, being held here June 18-21. “The combination [...]

NICE Denies Patient Access To Breakthrough Skin Cancer Pill

Negative draft decision for Zelboraf (vemurafenib) highlights challenges facing future value-based pricing implementation and UK access to medicines. Roche is extremely disappointed with the preliminary decision that NICE is not planning to recommend Zelboraf (vemurafenib) to be available on the NHS for the treatment of BRAF mutation positive unresectable or metastatic melanoma. While NICE recognises [...]